Thermo Fisher Scientific Contract Assets, Non-Current remained flat by 0.0% to $1.00M in Q1 2026 compared to the prior quarter.
An increase indicates strong long-term contract performance but may signal potential future cash flow delays, while a decrease suggests faster billing cycles.
This represents the company's right to consideration for goods or services transferred to a customer that are not yet bi...
Standard for SaaS companies with multi-year enterprise agreements and complex revenue recognition schedules.
contract_assets_noncurrent| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | $1.00M | $1.00M |
| QoQ Change | — | +0.0% |